Hepatorenal syndrome

Clinics in Liver Disease

Volumn 4, Issue 2, 2000, Pages 487-507

  Bataller, Ramón ^a   Ginès, Pere ^a   Arroyo, Vicente ^b   Rodés, Juan ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; METARAMINOL; MIDRODINE; MISOPROSTOL; NORADRENALIN; OCTREOTIDE; ORNIPRESSIN; PROSTAGLANDIN A1; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; SARALASIN; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTERY BLOOD FLOW; ASCITES; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEPATORENAL SYNDROME; HUMAN; KALLIKREIN KININ SYSTEM; LIVER TRANSPLANTATION; NONHUMAN; PATHOGENESIS; PERITONEUM VEIN SHUNT; PORTOCAVAL SHUNT; PROGNOSIS; REVIEW; RISK FACTOR; VASOCONSTRICTION;

EID: 0033926947     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70120-3     Document Type: Article

References (78)

1. A. Albillos J.L. Lledo I. Rossi Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function Gastroenterology 109 1995 1257
2. A. Alvestrand J. Bergstrom Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: Deficient production of this hormone in hepatic failure causes hepatorenal syndrome Lancet 1 1984 195
3. P. Angeli W. Jiménez V. Arroyo Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites Hepatology 20 1994 948
4. P. Angeli R. Volpin G. Gerunda Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octeotride Hepatology 29 1999 1690
5. S. Ariyan T. Sweeney M.D. Kerstein The hepatorenal syndrome: Recovery after portacaval shunt Ann Surg 181 1975 847
6. V. Arroyo R. Bataller M. Guevara Treatment of hepatorenal syndrome in cirrhosis V. Arroyo Ginès P. Rodés J. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis, Diagnosis, and Treatment 1999 Blackwell Science Malden 492
7. V. Arroyo J. Bosch F. Rivera The renin-angiotensin system in cirrhosis. Its relation to functional renal failure E. Bartoli Chiandussi Hepato-renal Syndrome 1979 Piccin Medical Books Padua 201
8. V. Arroyo P. Ginès A. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Hepatology 23 1996 164
9. V. Arroyo P. Ginès A. Rimola Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesis Am J Med 81 1986 104
10. V. Arroyo P. Ginès TIPS and refractory ascites. Lessons from recent history of ascites therapy J Hepatol 25 1996 221
11. 2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion Eur J Clin Invest 13 1983 271
12. R. Bataller P. Ginès M. Guevara Hepatorenal syndrome Semin Liver Dis 17 1997 233
13. W.M. Bennet E. Keefe C. Melnyk Response to dopamine hydrochloride in the hepatorenal syndrome Arch Intern Med 135 1975 964
14. J. Clària W. Jiménez J. Ros Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide Hepatology 15 1992 343
15. L. Daghestani C. Pomeroy Renal manifestations of hepatitis C infection Am J Med 106 1999 347
16. M. Epstein D.P. Berck N.K. Hollemberg Renal failure in the patient with cirrhosis. The role of active vasoconstriction Am J Med 49 1970 175
17. J. Fernández-Seara J. Prieto J. Quiroga Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure Gastroenterology 97 1989 1304
18. 1 analogue) and albumin administration J Hepatol 11 1990 153
19. A. Flint Clinical report on hydro-peritoneum, based on an analysis of forty-six cases Am J Med Sci 45 1963 306
20. A. Follo J.M. Llovet M. Navasa Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis Hepatology 20 1994 1495
21. E.H. Forrest R. Jalan P.C. Hayes Review article: Renal circulatory changes in cirrhosis-pathogenesis and therapeutic prospects Aliment Pharmacol Ther 10 1996 219
22. W.D. Fullen Hepatorenal syndrome: Reversal by peritoneovenous shunt Surgery 82 1977 337
23. J. Garcia-Estañ N. Atucha J. Mario Increased endothelium-dependent renal vasodilation in cirrhotic rats Am J Physiol 267 1994 R549
24. A. Ginès A. Escorsell P. Ginès Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis Gastroenterology 105 1993 229
25. 2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure J Hepatol 17 1993 220
26. P. Ginès V. Arroyo Hepatorenal syndrome J Am Soc Nephrol 10 1999 1833
27. P. Ginès G. Fernández-Esparrach V. Arroyo Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment Baillieres Clin Gastroenterol 11 1997 365
28. P. Ginès J. Rodés Clinical disorders of renal function in cirrhosis with ascites V. Arroyo Ginès P. Rodés J. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis, Diagnosis, and Treatment 1999 Blackwell Science Malden 36
29. P. Ginès R.W. Schrier The arterial vasodilation hypothesis of ascites formation in cirrhosis V. Arroyo Ginès P. Rodés J. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis, Diagnosis, and Treatment 1999 Blackwell Science Malden 411
30. P. Ginès L.I. Titó V. Arroyo Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 1988 1493
31. T.A. Gonwa A.H. Wilkinson Liver transplantation and renal function: Results in patients with and without hepatorenal syndrome M. Epstein The Kidney in Liver Disease ed 4 1996 Hanley & Belfus Philadelphia 529
32. D.L. Gornel R.G. Lancestremere S. Papper Acute changes in renal excretion of sodium and solute in patients with Laennec's cirrhosis, induced by the administration of the pressor amine, metaraminol J Clin Invest 41 1963 594
33. M. Guevara C. Bru P. Ginès Increased cerebrovascular resistance in cirrhotic patients with ascites Hepatology 28 1998 39
34. M. Guevara P. Ginès J.C. Bandi Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome. Effects on renal function and vasoactive systems Hepatology 27 1998 35
35. M. Guevara P. Ginès G. Fernández-Esparrach Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion Hepatology 27 1998 35
36. V. Gülberg M. Bilzer G. Paumgartner Ornipressin for treatment of hepatorenal syndrome (HRS) type I: Results of longterm therapy or retreatment Hepatology 28 1998 554A
37. A. Hadengue A. Gadano R. Moreau Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome J Hepatol 29 1998 565
38. J.H. Henriksen H. Ring-Larsen Hepatorenal disorders: Role of the sympathetic nervous system Semin Liver Dis 14 1994 35
39. M. Huber S. Kastner J. Scholmerich Analysis of cysteinyl leukotrienes in human urine: Enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome Eur J Clin Invest 19 1989 53
40. S. Iwatsuki M.M. Popovtzer J.L. Corman Recovery from “hepatorenal syndrome” after orthotopic liver transplantation N Engl J Med 280 1969 1367
41. D.R. Jeyarajah T.A. Gonwa M. McBride Hepatorenal syndrome: Combined liver-kidney transplants versus isolated liver transplant Transplantation 27 1997 1760
42. M.C. Kew P.W. Brunt R.R. Varma Renal and intrarenal blood-flow in cirrhosis of the liver Lancet 2 1971 504
43. M.H. Koppel J.N. Coburn M.M. Mims Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease N Engl J Med 289 1969 1155
44. R.G. Lancestremere P.L. Davidson Le Earley Renal failure in Laennec's cirrhosis: II. Simultaneous determination of cardiac output and renal hemodynamics J Clin Invest 41 1962 1922
45. J.H. Laragh P.J. Cannon C.J. Bentzel Angiotensin II, norepinephrine and renal transport of electrolytes and water in normal man and in cirrhosis with ascites J Clin Invest 42 1963 1179
46. K. Lenz H. Hörnatgl W. Druml Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis Gastroenterology 101 1991 1060
47. J.A. Levicki A.A. Protter Physiological studies of the natriuretic peptide family J.H. Laragh B.H. Brenner Hypertension: Pathphysiology, Diagnosis and Management 1995 Raven New York 1029
48. J. Llach P. Ginès V. Arroyo Effect of dipyridamole on kidney function in cirrhosis Hepatology 17 1993 59
49. A. Maroto A. Ginès J. Saló Diagnosis of functional renal failure of cirrhosis by Doppler sonography. Prognostic value of resistive index Hepatology 20 1994 839
50. A. Maroto P. Ginès V. Arroyo Brachial and femoral artery blood flow in cirrhosis: Relationship to kidney dysfunction Hepatology 17 1993 788
51. P.Y. Martin P. Ginès R.W. Schrier Role of nitric oxide as mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis N Engl J Med 339 1998 533
52. K. Moore J. Wendon M. Frazer Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome N Engl J Med 327 1992 1774
53. K. Moore The hepatorenal syndrome Clin Sci (Colch) 92 1997 433
54. M. Navasa A. Follo X. Filella Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality Hepatology 27 1998 1227
55. M. Navasa A. Rimola J. Rodés Bacterial infections in liver disease Semin Liver Dis 17 1997 323
56. S. Papper J.L. Belsky K.H. Bleifer Renal failure in Laennec's cirrhosis of the liver: I. Description of clinical and laboratory features Ann Intern Med 51 1959 759
57. S. Papper Hepatorenal syndrome M. Epstein The Kidney in Liver Disease ed. 1 1978 Elsevier Biomedical New York 91
58. R.M. Pérez-Ayuso V. Arroyo J. Camps Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis Kidney Int 26 1986 72
59. J.F. Platt J.H. Ellis J.M. Rubin Renal duplex doppler ultrasonography: A noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease Hepatology 20 1994 362
60. E. Quintero P. Ginès V. Arroyo Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites Nephron 42 1986 298
61. A. Rimola M. Navasa L. Grande Liver transplantation in cirrhotic patients with ascites V. Arroyo Ginès P. Rodés J. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis, and treatment 1999 Blackwell Science Malden 522
62. H. Ring-Larsen J.H. Henriksen N.J. Christenses Increased sympathetic activity in cirrhosis N Engl J Med 308 1983 1209
63. J. Ros W. Jiménez M. Bosch-Marcé Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis Hepatology 21 1995 915
64. D. Sacerdoti M. Bolognesi C. Merkel Renal vasoconstriction in cirrhosis evaluated by Duplex Doppler ultrasonography Hepatology 17 1993 219
65. R. Safirstein M.F. Levitt A hepatorenal depressor reflex: A possible clue to the pathogenesis of the hepatorenal syndrome Hepatology 14 1991 734
66. F. Salerno S. Badalamenti Drug-induced renal failure in cirrhosis V. Arroyo Ginès P. Rodés J. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis, Diagnosis, and Treatment 1999 Blackwell Science Malden 511
67. J.M. Salmerón L. Ruiz del Arbol A. Ginès Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis Hepatology 17 1993 800
68. E.T. Schroeder R.H. Eich H. Smulyan Plasma renin level in hepatic cirrhosis. Relation to functional renal failure Am J Med 49 1970 186
69. L. Shear J. Kleinerman G.J. Gabuzda Renal failure in patients with cirrhosis of the liver: Clinical and pathological characteristics Am J Med 39 1965 184
70. M.L. Shiffman L. Jeffers J.H. Hoofnagle The role of transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Disease advisory board Hepatology 25 1995 1591
71. K.A. Somberg Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites and hepatorenal syndrome M. Epstein The Kidney in Liver Disease ed 4 1996 Hanley & Belfus Philadelphia 507
72. P.R. Soper A.B. Latif M.R. Bending Amelioration of hepatorenal syndrome with selective endothelin-A anatagonist Lancet 347 1996 1842
73. P. Sort M. Navasa V. Arroyo Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 5 1999 403
74. T.M. Sturgis Hepatorenal syndrome: Resolution after transjugular intrahepatic portosystemic shunt J Clin Gastroenterol 20 1995 241
75. S. Wapnick S. Grosberg M. Kinney LeVeen continuous peritoneal-jugular shunt: Improvement of renal function in ascitic patients JAMA 237 1977 131
76. B. Yersin M. Burnier P. Magnenat Improvement of renal failure with repeated head-out water immersions in patients with hepatorenal syndrome associated with alcoholic hepatitis Am J Nephrol 15 1995 260
77. R.D. Zipser I. Kronborg W. Rector Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome Gastroenterology 87 1984 1228
78. 1 Prostaglandins 13 1977 819